Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer.

BMC Cancer · 2009 · PMC2796678 · PMID 19958548

Europe PMC DOI

hedged sentence

0.0029

closest p · 0.1× alpha

0.0029

boldest claim

The sentences

highly significantp < 0.0029actually significant

Kaplan-Meier curves for overall survival showed highly significant differences in patients with remission (R), and no change (NC) or progression (P) at time of staging investigations after the third therapy cycle (p < 0.0029 between R and NC; p < 0.0001 between R and P; Figure 1A ) with median survival times of 528 (R), 328 (NC), and 327 (P) days, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.